↓ Skip to main content

Conducting Phase I Trials During the SARS-Coronavirus-2 Outbreak: About Science and Care

Overview of attention for article published in Frontiers in oncology, May 2020
Altmetric Badge

About this Attention Score

  • Average Attention Score compared to outputs of the same age
  • Good Attention Score compared to outputs of the same age and source (76th percentile)

Mentioned by

twitter
4 X users

Citations

dimensions_citation
3 Dimensions

Readers on

mendeley
64 Mendeley
Title
Conducting Phase I Trials During the SARS-Coronavirus-2 Outbreak: About Science and Care
Published in
Frontiers in oncology, May 2020
DOI 10.3389/fonc.2020.00926
Pubmed ID
Authors

Angelo Dipasquale, Pasquale Persico, Elena Lorenzi, Monica Bertossi, Armando Santoro, Matteo Simonelli

X Demographics

X Demographics

The data shown below were collected from the profiles of 4 X users who shared this research output. Click here to find out more about how the information was compiled.
As of 1 July 2024, you may notice a temporary increase in the numbers of X profiles with Unknown location. Click here to learn more.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 64 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 64 100%

Demographic breakdown

Readers by professional status Count As %
Other 8 13%
Researcher 7 11%
Student > Master 7 11%
Student > Ph. D. Student 6 9%
Student > Bachelor 5 8%
Other 15 23%
Unknown 16 25%
Readers by discipline Count As %
Medicine and Dentistry 21 33%
Biochemistry, Genetics and Molecular Biology 5 8%
Nursing and Health Professions 5 8%
Social Sciences 3 5%
Pharmacology, Toxicology and Pharmaceutical Science 2 3%
Other 10 16%
Unknown 18 28%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 3. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 23 May 2020.
All research outputs
#15,102,687
of 25,387,668 outputs
Outputs from Frontiers in oncology
#4,422
of 22,433 outputs
Outputs of similar age
#222,484
of 425,052 outputs
Outputs of similar age from Frontiers in oncology
#108
of 476 outputs
Altmetric has tracked 25,387,668 research outputs across all sources so far. This one is in the 40th percentile – i.e., 40% of other outputs scored the same or lower than it.
So far Altmetric has tracked 22,433 research outputs from this source. They receive a mean Attention Score of 3.0. This one has done well, scoring higher than 79% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 425,052 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 47th percentile – i.e., 47% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 476 others from the same source and published within six weeks on either side of this one. This one has done well, scoring higher than 76% of its contemporaries.